-
Who we are Suggested text: Our website address is: https://lustgarten.org. Comments Suggested text: When visitors leave comments on the site we collect the data shown in the comments form, and […]
Sep 07,2021
-
Messenger RNA (mRNA) vaccines may be the hottest thing in science now as they help turn the tide against COVID-19. But even before the pandemic began, Memorial Sloan Kettering researchers […]
Jul 06,2021
-
Results from an ongoing phase 2b GRECO-2 clinical trial show that the novel drug GC4419 may be promising in treating patients with unresectable or borderline resectable locally advanced pancreatic cancer […]
Oct 01,2021
-
Newswise — A large international collaboration led by researchers from the Johns Hopkins Kimmel Cancer Center has identified promising new targets for pancreatic cancer treatment and early diagnosis after examining […]
Oct 01,2021
-
By Kerri Kaplan As the world’s primary catalyst for pancreatic cancer research, the Lustgarten Foundation funds critical research projects where creative risks yield high rewards. Lustgarten is driving forward basic […]
Oct 01,2021
-
By Ellen Zimmerman The Therapeutics-Focused Research Program will advance the understanding of the causes and progression of pancreatic cancer and will identify new potential therapies. This grant program will stimulate […]
Aug 13,2021
-
New combination of three existing immunotherapy drugs may eliminate pancreatic tumors By Stephanie Elsea When it comes to fighting and destroying infected or diseased cells, T cells are the heroes. The body’s front line of defense, T cells are like soldiers deployed at […]
Aug 13,2021
-
Why do alterations of certain genes cause cancer only in specific organs of the human body? Scientists at the German Cancer Consortium (DKTK), the Technical University of Munich (TUM), and […]
Jul 19,2021